From the UALCAN database, we found that the expression of IFI16 in ccRCC patients (n = 533) was significantly upregulated compared with expression in the adjacent tissues (n = 72) (Figure 1A). This evidence concerns the gene IFI16 and nonpapillary renal cell carcinoma.